Literature DB >> 3120101

Cystic fibrosis--an otolaryngologic perspective.

R Cepero1, R J Smith, F I Catlin, K L Bressler, G T Furuta, K C Shandera.   

Abstract

Cystic fibrosis (CF) is the most common lethal genetic disorder in white patients. The protean manifestations of the disease result from exocrine gland dysfunction and include chronically debilitating pulmonary and pancreatic compromise and clinically inconsequential (although diagnostically extremely important) sweat electrolyte abnormalities. The subject of this article is the otolaryngologic manifestations of the disease, based on a retrospective analysis of 450 cases. Nasal polyposis and sinusitis occurred in 10% and 11% of patients, respectively, and polypectomy was, after laparotomy, the most common surgical procedure these children underwent. The extent of intranasal surgery for polyposis was found to be inversely proportional to the recurrence rate. A simple polypectomy was relatively ineffective treatment; when performed in conjunction with a Caldwell-Luc and either an intranasal or extranasal ethmoidectomy, the recurrence rate was less than 13%. Otologic problems, found in 8% of patients, included chronic otitis media (2.5%) and acute otitis media (5.5%). Only five patients required pressure-equalizing tubes. Recent genetic advances of immense importance are also described. Although the basic gene defect has yet to be elucidated, by use of a technique known as restriction-fragment-linked polymorphism, the gene associated with CF has been found in the middle of the long arm of chromosome 7. By following gene markers closely associated with this gene, it is possible to do carrier tests within affected families and, if certain criteria are met, perform prenatal diagnosis. Eventual isolation and characterization of the gene will follow, hopefully making prevention possible and treatment more effective.

Entities:  

Mesh:

Year:  1987        PMID: 3120101     DOI: 10.1177/019459988709700403

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  25 in total

Review 1.  Sinus disease in cystic fibrosis.

Authors:  G K Mak; N R Henig
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

2.  Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease.

Authors:  Kiranya E Tipirneni; Do-Yeon Cho; Daniel F Skinner; Shaoyan Zhang; Calvin Mackey; Dong-Jin Lim; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2017-08-03       Impact factor: 3.325

Review 3.  How to Assess, Control, and Manage Uncontrolled CRS/Nasal Polyp Patients.

Authors:  Rahuram Sivasubramaniam; Richard J Harvey
Journal:  Curr Allergy Asthma Rep       Date:  2017-09       Impact factor: 4.806

Review 4.  ENT surgery and cystic fibrosis.

Authors:  A R Maw
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 5.  Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management.

Authors:  Jordan Heath; Larry Hartzell; Claire Putt; Joshua L Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-29       Impact factor: 4.806

Review 6.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

7.  Extensive surgical and comprehensive postoperative medical management for cystic fibrosis chronic rhinosinusitis.

Authors:  Frank W Virgin; Steven M Rowe; Mary B Wade; Amit Gaggar; Kevin J Leon; K Randall Young; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

8.  [Routine otorhinolaryngological examination in patients with cystic fibrosis].

Authors:  A Koitschev; A Wolff; C Koitschev; S Preyer; R Ziebach; M Stern
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

9.  Cystic fibrosis transmembrane conductance regulator function, not TAS2R38 gene haplotypes, predict sinus surgery in children and young adults with cystic fibrosis.

Authors:  Nicholas M Dalesio; Melis A Aksit; Kwangmi Ahn; Karen S Raraigh; Joseph M Collaco; Sharon McGrath-Morrow; Pamela L Zeitlin; Steven S An; Garry R Cutting
Journal:  Int Forum Allergy Rhinol       Date:  2020-04-13       Impact factor: 3.858

Review 10.  Sinusitis in patients with cystic fibrosis.

Authors:  Y Hui; R Gaffney; W S Crysdale
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.